A New Tool for Helping Labs Improve Diversity in Clinical Trials
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
Open Content
Subscribe today for access to
Articles and Reports
G2 Intelligence Has Some Exciting News to Share!
G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight
Is a Newly Proposed Rule Meant to Stop Healthcare Consolidation?
The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.
HHS Issues Final Rules for Surprise Billing Price Dispute Resolution
The process is now slightly less rigged in insurers’ favor.
Health System and Care Providers Settle FCA Allegations for $70.7M
Ventura County’s organized health system and three medical care providers were accused of falsely billing Medi-Cal.
New Test May Make It Faster, Cheaper, and Easier to Detect Aneuploidy
New Short-read Transpore Rapid Karyotyping test can identify fetal chromosomal abnormalities in a variety of samples.
Can You Increase Your Bottom Line While Putting Patients First?
Technology can make it possible for labs and other healthcare providers to boost revenue while still providing a positive patient experience.
SNAP Diagnostics Pays $3.9M to Settle Sleep Testing False Claims Charges
Federal enforcers and whistleblowers home in on billing of medically unnecessary sleep tests.
Cases of Undiagnosed Diabetes Are Declining in the US
A recent study shows that the proportion of undiagnosed diabetes has dropped over the past three decades, but certain groups are more affected.
CMS Proposes 20 Percent Increase to CLIA Lab User Fees
A new rule proposed by the agency would also mean new fees for follow-up and complaint surveys.
Home Healthcare Business Owner to See Prison Time for $10M Fraud
In key enforcement actions announced over the last week, a Texas-based owner faces 60 months behind bars for defrauding Medicare.
Don’t Trust a Negative At-Home COVID-19 Test Result, FDA Warns
The agency is recommending repeat testing with at home COVID-19 antigen tests, regardless of actual symptoms.
LDTs Legislation Inches Closer to Passage, but Major Hurdles Remain
The VALID Act for FDA regulation of laboratory developed tests is working its way through the final stages of the legislative process, but not everyone is loving it.
